SCHEMBL6432013

SCHEMBL6432013

COc1cc2c(Nc3cc(O[Si](c4ccccc4)(c4ccccc4)C(C)(C)C)c(Cl)cc3F)ccnc2cc1OCc1nccn1C

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FLT1 P17948 8/20 0.49
FGFR1 P11362 6/20 0.49
SRC P12931 3/20 0.46
KDR P35968 9/20 0.45
RET P07949 1/20 0.45
EGFR P00533 5/20 0.44
EPHA2 P29317 2/20 0.41
EPHB4 P54760 2/20 0.41
ERBB2 P04626 1/20 0.41
MET P08581 1/20 0.39
MAPK14 Q16539 1/20 0.39
FLT4 P35916 3/20 0.37
GAK O14976 1/20 0.37
FGFR2 P21802 2/20 0.37
FGFR4 P22455 2/20 0.37
FGFR3 P22607 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7460012 0.91 RET (0.55) FLT1FGFR1KDRRETEGFR
SCHEMBL6431182 0.89 EGFR (0.54) FLT1FGFR1SRCKDREGFR
SCHEMBL6432661 0.87 FLT1 (0.55) FLT1FGFR1SRCKDREGFR
SCHEMBL6434966 0.86 FLT1 (0.51) FLT1FGFR1SRCKDREGFR
SCHEMBL6432008 0.84 FLT1 (0.46) FLT1FGFR1SRCKDRRET
Hydrochloric Acid SCHEMBL6434134 0.84 FLT1 (0.69) FLT1FGFR1SRCKDRRET
SCHEMBL6432182 0.83 FLT1 (0.70) FLT1FGFR1SRCKDRRET
SCHEMBL6431016 0.82 EGFR (0.53) FLT1FGFR1SRCKDRRET
SCHEMBL6431467 0.82 FLT1 (0.54) FLT1FGFR1SRCKDREGFR
SCHEMBL7451653 0.78 EGFR (0.59) FLT1FGFR1SRCKDRRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0929526-B1 QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF ASTRAZENECA AB (SE) 2005-07-27 EP disclosed
US-6809097-B1 ANTIANGIOGENIC AND/OR VASCULAR PERMEABILITY ZENECA LIMITED (GB) 2004-10-26 US disclosed